TY  - GEN

T1  - 42924 Treatment-Emergent Adverse Events in Patients Aged 6 Months to 5 Years With Moderate-to- Severe Atopic Dermatitis Treated With Dupilumab in an Open-Label Extension Clinical Trial

PY  - 2023/09/01

AU  - Paller A

AU  - Siegfried E

AU  - Sidbury R

AU  - Cork M

AU  - Pinter A

AU  - Xiao J

AU  - Stanton S

AU  - Khokhar F

AU  - Bansal A

AU  - Prescilla R

ED  - 

Y2  - 2024/12/22

ER  -